Type 2 diabetes: open trials in South Korea

69 open trials have a site in South Korea. Registry data; only the trial team decides who can take part.

NCT07595549
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Trial Treatment · Phase 3 · Pfizer
Hallym University Sacred Heart Hospital, Anyang-si · Konyang University Hospital, Daejeon · Gachon University Gil Medical Center, Incheon · Kangbuk Samsung Hospital, Seoul · Pusan National University Yangsan Hospital, Yangsan
Registry updated 2026-11-05
NCT07668336
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
Trial Treatment · Phase 3 · Eli Lilly and Company
Soon Chun Hyang University Bucheon Hospital, Bucheon-si · Kyungpook National University Chilgok Hospital, Deagu · Chungnam national university hospital, Junggu · Seoul National University Bundang Hospital, Seongnam · Seoul National University Hospital, Seoul
Registry updated 2026-11-05
NCT07282600
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Trial Treatment · Phase 3 · Eli Lilly and Company
Korea University Ansan Hospital, Ansan-si · Hanyang University Guri Hospital, Guri-si · Chosun University Hospital, Gwangju · Seoul National University Bundang Hospital, Seongnam · Severance Hospital, Yonsei University Health System, Seoul
Registry updated 2026-11-04
NCT07881458
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Trial Treatment · Phase 3 · Eli Lilly and Company
Korea University Ansan Hospital, Ansan-si · Chosun University Hospital, Gwangju · Seoul National University Bundang Hospital, Seongnam · Nowon Eulji Medical Center, Eulji University, Seoul · Severance Hospital, Yonsei University Health System, Seoul
Registry updated 2026-11-04
NCT07881432
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Trial Treatment · Phase 3 · Eli Lilly and Company
Korea University Ansan Hospital, Ansan-si · Pusan National University Yangsan Hospital, Busan · Hanyang University Guri Hospital, Guri-si · Chosun University Hospital, Gwangju · Yeungnam Univeristy Medical Center, Gyeongsan-si · Kyungpook National University Hospital, Junggu · Gachon University Gil Medical Center, Namdong-gu · Konyang University Hospital, Seogu · Seoul National University Bundang Hospital, Seongnam · CHA Bundang Medical Center, CHA University, Seongnam-si · Nowon Eulji Medical Center, Eulji University, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Seoul National University Hospital, Seoul
Registry updated 2026-11-03
NCT07900633
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Trial Treatment · Phase 3 · Eli Lilly and Company
The Catholic University of Korea, Bucheon St. Mary's Hospital, Bucheon-si · Kosin University Gospel Hospital, Busan · Hanyang University Guri Hospital, Guri-si · Chosun University Hospital, Gwangju · Yeungnam Univeristy Medical Center, Gyeongsan-si · Inha University Hospital, Incheon · Konyang University Hospital, Seogu · Seoul National University Bundang Hospital, Seongnam · Korea University Anam Hospital, Seoul · The Catholic Univ. of Korea Seoul St. Mary's Hospital, Seoul · Asan Medical Center, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Nowon Eulji Medical Center, Eulji University, Seoul · Ulsan University Hospital, Ulsan · Yonsei University Wonju Severance Christian Hospital, Wŏnju
Registry updated 2026-11-03
NCT07662109
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
Trial Treatment · Phase 3 · AstraZeneca
Busan · Goyang-si · Guri-si · Gwangju · Gyeonggi-do · Seoul · Suwon · Yangsan
Registry updated 2026-10-30
NCT07784725
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Trial Treatment · Phase 3 · AstraZeneca
Anyang · Bucheon-si · Daegu · Seoul · Yangsan
Registry updated 2026-10-30
NCT07064473
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Trial Treatment · Phase 3 · Boehringer Ingelheim
Korea University Ansan Hospital, Ansan-si · The Catholic University of Korea, Bucheon St. Mary's Hospital, Bucheon-si · Pusan National University Hospital, Busan · Inje University Busan Paik Hospital, Busan · Eulji University Hospital, Daejeon · Chungnam National University Hospital, Daejoen · Chonnam National University Hospital, Gwangju · Inha University Hospital, Incheon · Seoul National University Bundang Hospital, Seongnam · Asan Medical Center, Seoul · Severance hospital, Seoul · Korea University Anam Hospital, Seoul · Hanyang University Medical Center, Seoul · The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Seoul National University Hospital, Seoul · Ajou University Hospital, Suwon · Yonsei University Wonju Severance Christian Hospital, Wŏnju
Registry updated 2026-10-28
NCT07784270
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Trial Treatment · Phase 3 · AstraZeneca
Busan · Daegu · Daejeon · Incheon · Seoul · Suwon
Registry updated 2026-10-28
NCT07662213
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Trial Treatment · Phase 3 · AstraZeneca
Busan · Changwon-si · Daegu · Daejeon · Guri-si · Incheon · Seoul
Registry updated 2026-10-22
NCT07890740
Continuous Glucose Monitoring and Dietary Self-Management in Adults in Namwon
Trial Treatment · Ji-Yeob Choi
Namwon Senior Welfare Center, Namwon · Namwon Medical Center, Namwon · Namwon City Hall, Namwon · Namwon Public Health Center, Namwon
Registry updated 2026-10-22
NCT06220773
A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy
Trial Treatment · Phase 3 · Boryung Pharmaceutical Co., Ltd
Severance hospital, Seoul
Registry updated 2026-10-16
NCT07351045
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Trial Treatment · Phase 3 · Hoffmann-La Roche
Kyungpook National University Hospital, Daegu · Konyang University Hospital, Daejeon · Chosun University Hospital, Gwangju · Hanyang University Guri Hospital, Gyeonggi-do · Bucheon St Mary's hospital, Gyeonggi-do · Gachon University Gil Medical Center, Incheon · Seoul National University Bundang Hospital, Seongnam-si · Asan Medical Center, Seoul · Kangbuk Samsung Hospital, Seoul · Seoul National University Hospital, Seoul
Registry updated 2026-10-13
NCT07351058
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Trial Treatment · Phase 3 · Hoffmann-La Roche
Eulji University Hospital, Daejeon · Yonsei University Wonju Severance christian hospital, Gangwon-do · Chosun University Hospital, Gwangju · Uijeongbu St. Mary's Hospital, Gyeonggi-do · Seoul National University Bundang Hospital, Seongnam-si · Gangdong Kyung Hee University Hospital, Seoul · Hallym University Kangnam Sacred Heart Hospital, Seoul · Kangbuk Samsung Hospital, Seoul · Eulji general hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul
Registry updated 2026-10-13
NCT07667803
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Trial Treatment · Phase 3 · AstraZeneca
Busan · Daegu · Goyang-si · Gyeonggi-do · Incheon · Jongno-gu · Seoul · Suwon
Registry updated 2026-10-13
NCT07668388
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Trial Treatment · Phase 2 · Novo Nordisk A/S
Chosun University Hospital_Endocrinology, Gwangju · The Catholic University of Korea, Seoul ST. Mary's Hospital_Endocrinology, Seoul · Asan Medical Center_Endocrinology, Seoul · Korea University Guro Hospital_Endocrinology, Seoul
Registry updated 2026-10-07
NCT06838286
Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes
Research · Chong Kun Dang Pharmaceutical
Seoul National University Bundang Hospital, Seongnam-si
Registry updated 2026-09-30
NCT07533175
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Trial Treatment · Phase 3 · Novo Nordisk A/S
Chonnam National University Hospital_Endocrinology, Gwangju · Seoul National University Hospital_Endocrinology, Seoul · Asan Medical Center_Endocrinology, Seoul · The Catholic University of Korea, Yeouido ST. Mary's Hospital_Endocrinology, Seoul · Kyunghee University Medical Center_Endocrinology, Seoul · Severance Hospital, Yonsei University Health System_Endocrinology, Seoul · Seoul National University Bundang Hospital_Endocrinology, Seoungnam-si
Registry updated 2026-09-30
NCT07595718
AI-Based Phenome Data Analysis for Predicting the Onset of Major Diseases
Research · Jae Yong Jeon, MD
Seoul ASAN Medical Center, Seoul
Registry updated 2026-09-24
NCT07321886
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Trial Treatment · Phase 3 · Eli Lilly and Company
Gachon University Gil Medical Center, Namdong-gu · Konyang University Hospital, Seogu · Seoul National University Bundang Hospital, Seongnam · Seoul National University Hospital, Seoul · Pusan National University Yangsan Hospital, Yangsan
Registry updated 2026-09-22
NCT07415954
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Trial Treatment · Phase 2 · Novo Nordisk A/S
Korea University Ansan Hospital_Endocrinology, Ansan-si · Nowon Eulji Medical Center, Eulji University_Endocrinology, Seoul · Kangbuk Samsung Hospital_Endocrinology, Seoul · Pusan National University Yangsan Hospital_Family Medicine, Yangsan
Registry updated 2026-09-11
NCT07662044
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
Trial Treatment · Phase 3 · AstraZeneca
Jongno-gu · Seongnam-si · Seoul
Registry updated 2026-08-31
NCT07770737
Cardioprotective Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Korean Patients With Type 2 Diabetes
Research · Dongtan Sacred Heart Hospital
Hallym University Dongtan Sacred Heart Hospital, Hwaseong-si
Registry updated 2026-08-18
NCT07280780
CGM-Based Glycemic Analysis After ESI
Research · Korea University Anam Hospital
Korea University Anam Hospital, Seoul
Registry updated 2026-08-12

All Type 2 diabetes trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error